Wang XH - Search Results

1

Multi-institutional validation of novel models for predicting the prognosis of patients with huge hepatocellular carcinoma.

Wang XH, Liu QB, Xiang CL, Mao XH, Yang B, Li Q, Zhou QF, Li SQ, Zhou ZG, Chen MS. Wang XH, et al. Int J Cancer. 2021 Jul 1;149(1):127-138. doi: 10.1002/ijc.33516. Epub 2021 Feb 27. Int J Cancer. 2021. PMID: 33586134 Free article.

2

An inflammatory biomarker-based nomogram to predict prognosis of patients with nasopharyngeal carcinoma: an analysis of a prospective study.

Li XH, Chang H, Xu BQ, Tao YL, Gao J, Chen C, Qu C, Zhou S, Liu SR, Wang XH, Zhang WW, Yang X, Zhou SL, Xia YF. Li XH, et al. Among authors: wang xh. Cancer Med. 2017 Jan;6(1):310-319. doi: 10.1002/cam4.947. Epub 2016 Nov 10. Cancer Med. 2017. PMID: 27860387 Free PMC article.

3

Surrogate endpoints shortening the therapeutic evaluation duration for different subgroups of patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy: A retrospective analysis of 830 patients stratified by the 8th edition of the UICC/AJCC staging system and plasma Epstein-Barr viral.

Zhou S, Chen C, Liu SR, Tao YL, Chang H, Wang XH, Yang X, Zhang WW, Liu S, Ding SR, Wang GN, Xia YF. Zhou S, et al. Among authors: wang xh, wang gn. J Cancer. 2018 Sep 8;9(18):3352-3360. doi: 10.7150/jca.25530. eCollection 2018. J Cancer. 2018. PMID: 30271496 Free PMC article.

4

O Blood Type Is Associated with Unfavorable Distant-metastasis-free Survival in Female Patients with Nasopharyngeal Carcinoma: A Retrospective Study of 2439 Patients from Epidemic Area.

Wang GN, Zhou S, Chen C, Chang H, Tao Y, Liu S, Wang XH, Zhang WW, Liu Y, Liu SR, Ding SR, Yang X, Ye ZQ, Gao YF, Xia YF. Wang GN, et al. Among authors: wang xh. J Cancer. 2019 Jan 30;10(5):1297-1306. doi: 10.7150/jca.28372. eCollection 2019. J Cancer. 2019. PMID: 30854139 Free PMC article.

5

The prognostic significance of PD-L1 and PD-1 expression in patients with nasopharyngeal carcinoma: a systematic review and meta-analysis.

Huang ZL, Liu S, Wang GN, Zheng SH, Ding SR, Tao YL, Chen C, Liu SR, Yang X, Chang H, Wang XH, Xia YF. Huang ZL, et al. Among authors: wang xh, wang gn. Cancer Cell Int. 2019 May 22;19:141. doi: 10.1186/s12935-019-0863-5. eCollection 2019. Cancer Cell Int. 2019. PMID: 31139018 Free PMC article.

6

A nomogram predicting the recurrence of hepatocellular carcinoma in patients after laparoscopic hepatectomy.

Pan YX, Chen JC, Fang AP, Wang XH, Chen JB, Wang JC, He W, Fu YZ, Xu L, Chen MS, Zhang YJ, Li QJ, Zhou ZG. Pan YX, et al. Among authors: wang xh, wang jc. Cancer Commun (Lond). 2019 Oct 11;39(1):55. doi: 10.1186/s40880-019-0404-6. Cancer Commun (Lond). 2019. PMID: 31601270 Free PMC article.

7

Comparison of Microwave Ablation and Transarterial Chemoembolization for Single-Nodule Hepatocellular Carcinoma Smaller Than 5cm: A Propensity Score Matching Analysis.

Cui R, Wang XH, Ma C, Liu T, Cheng ZG, Han ZY, Liu FY, Yu XL, Yu J, Liang P. Cui R, et al. Among authors: wang xh. Cancer Manag Res. 2019 Dec 23;11:10695-10704. doi: 10.2147/CMAR.S213581. eCollection 2019. Cancer Manag Res. 2019. PMID: 31920380 Free PMC article.

8

Intention to control low central venous pressure reduced blood loss during laparoscopic hepatectomy: A double-blind randomized clinical trial.

Pan YX, Wang JC, Lu XY, Chen JB, He W, Chen JC, Wang XH, Fu YZ, Xu L, Zhang YJ, Chen MS, Lai RC, Zhou ZG. Pan YX, et al. Among authors: wang xh, wang jc. Surgery. 2020 Jun;167(6):933-941. doi: 10.1016/j.surg.2020.02.004. Epub 2020 Mar 23. Surgery. 2020. PMID: 32216964 Clinical Trial.

9

Perioperative blood transfusion has distinct postsurgical oncologic impact on patients with different stage of hepatocellular carcinoma.

Chen GX, Qi CY, Hu WJ, Wang XH, Hua YP, Kuang M, Peng BG, Li SQ. Chen GX, et al. Among authors: wang xh. BMC Cancer. 2020 May 29;20(1):487. doi: 10.1186/s12885-020-06980-5. BMC Cancer. 2020. PMID: 32471389 Free PMC article.

10

Preventive effect of celecoxib in sorafenib-related hand-foot syndrome in hepatocellular carcinoma patients, a single-center, open-label, randomized, controlled clinical phase III trial.

Chen JC, Wang JC, Pan YX, Yi MJ, Chen JB, Wang XH, Fu YZ, Zhang YJ, Xu L, Chen MS, Zhang RX, Zhou ZG. Chen JC, et al. Among authors: wang xh, wang jc. Am J Cancer Res. 2020 May 1;10(5):1467-1476. eCollection 2020. Am J Cancer Res. 2020. PMID: 32509392 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,992 results

Search Page